Business Trends Defining the Future of Managed Care Pharmacy

(EDU-B1) Prescription Digital Therapeutics: Formulary Design and Access Trends

Wednesday, October 12, 2022

9:45 AM – 11:00 AM ET

Location: Potomac B

ACPE UAN:N/A | Contact Hours: N/A | Activity Type: N/A

Faculty(s)

Jason Dinger, PhD

SVP - Strategy and Innovation
AmerisourceBergen
Nashville, TN
Kelly Price

Vice President, Market Access
Mahana Therapeutics
Fort Worth, TX
Tim S. Regan, BPharm, RPh, CPh

Vice President, Commercial Consulting
Xcenda, L.L.C., Carrollton, TX, USA
Carrollton, TX
Kat Wolf Khachatourian, PharmD, MBA

Associate Director, Field Medical Affairs (formerly Chief Quality Integration Officer)
Novo Nordisk (formerly of PSW / MultiCare Health System)
Sammamish, WA

Moderator(s)

Tim S. Regan, BPharm, RPh, CPh

Vice President, Commercial Consulting
Xcenda, L.L.C., Carrollton, TX, USA
Carrollton, TX

Please note this session is not accredited for continuing pharmacy education credit.

Attendees of this session will gain insights into payer perceptions and developer expectations in the rapidly expanding prescription digital therapeutics (PDTx) market. Content presented will explore current and future market trends in PDTx utilization, payer coverage, and reimbursement models as well as real-world success stories from payer and manufacturer stakeholders. Utilization of PDTx products will place an emphasis on increased adoption among patients and their potential place in therapy. Payer considerations will focus on PDTx evaluation and management that will promote more informed formulary decisions and appropriate patient access to these innovative therapies. Leveraging insights from extensive payer market research and client experience in the PDTx space, this session will provide a meaningful presentation to facilitate increased and aligned discussions on this new and emerging topic.

Learning Objectives:

At the completion of this activity, participants should be able to:

Explain key trends impacting the PDTx market and discuss how these products are currently utilized in the United States.
Discuss how payers are making informed coverage decisions and managing utilization from a formulary management perspective.
Identify key barriers and drivers that impact a PDTx product’s success in gaining market uptake.